News
Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...
Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today ...
Pharmaceutical Technology on MSN20h
IGI and AbbVie sign licence deal for cancer and autoimmune therapyIchnos Glenmark Innovation subsidiary IGI Therapeutics has signed an exclusive licensing agreement with AbbVie for ISB 2001, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback